331 related articles for article (PubMed ID: 8102127)
41. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of multiple drug resistance in human bladder cancer cell lines.
Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
[TBL] [Abstract][Full Text] [Related]
43. Isolation and characterization of doxorubicin-resistant Lewis lung carcinoma variants.
Bruno NA; Carver LA; Slate DL
Cancer Commun; 1990; 2(4):151-8. PubMed ID: 1973357
[TBL] [Abstract][Full Text] [Related]
44. Derivation and characterisation of a mouse tumour cell line with acquired resistance to cyclosporin A.
Wright KA; Twentyman PR
Eur J Cancer; 1993; 29A(3):389-94. PubMed ID: 8104444
[TBL] [Abstract][Full Text] [Related]
45. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
Germann UA; Shlyakhter D; Mason VS; Zelle RE; Duffy JP; Galullo V; Armistead DM; Saunders JO; Boger J; Harding MW
Anticancer Drugs; 1997 Feb; 8(2):125-40. PubMed ID: 9073309
[TBL] [Abstract][Full Text] [Related]
46. Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines.
Toffoli G; Viel A; Tumiotto L; Biscontin G; Rossi C; Boiocchi M
Br J Cancer; 1991 Jan; 63(1):51-6. PubMed ID: 1671208
[TBL] [Abstract][Full Text] [Related]
47. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.
Chen YN; Mickley LA; Schwartz AM; Acton EM; Hwang JL; Fojo AT
J Biol Chem; 1990 Jun; 265(17):10073-80. PubMed ID: 1972154
[TBL] [Abstract][Full Text] [Related]
48. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252
[TBL] [Abstract][Full Text] [Related]
49. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
50. Intracellular expression of P-glycoprotein in a human colon tumor cell line.
Duensing TD; Slate DL
Anticancer Res; 1994; 14(1A):13-9. PubMed ID: 7513140
[TBL] [Abstract][Full Text] [Related]
51. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
52. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.
Lai GM; Chen YN; Mickley LA; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):696-703. PubMed ID: 1682280
[TBL] [Abstract][Full Text] [Related]
53. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene.
Barrand MA; Heppell-Parton AC; Wright KA; Rabbitts PH; Twentyman PR
J Natl Cancer Inst; 1994 Jan; 86(2):110-7. PubMed ID: 7903701
[TBL] [Abstract][Full Text] [Related]
54. Expression of a human multidrug resistance gene in human ovarian carcinoma cell lines.
Sekiya S; Nunoyama T; Shirasawa H; Kimura H; Kawata M; Iijima N; Sugimoto Y; Tsuruo T; Takamizawa H
Arch Gynecol Obstet; 1992; 251(2):79-86. PubMed ID: 1349803
[TBL] [Abstract][Full Text] [Related]
55. Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.
Zalcberg JR; Hu XF; Wall DM; Mirski S; Cole S; Nadalin G; De Luise M; Parkin JD; Vrazas V; Campbell L
Int J Cancer; 1994 May; 57(4):522-8. PubMed ID: 7514153
[TBL] [Abstract][Full Text] [Related]
56. Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione S-transferase pi gene expression.
Ramachandran C; Yuan ZK; Huang XL; Krishan A
Biochem Pharmacol; 1993 Feb; 45(3):743-51. PubMed ID: 8095141
[TBL] [Abstract][Full Text] [Related]
57. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation.
Hill BT; Whelan RD; Hurst HC; McClean S
Cancer; 1994 Jun; 73(12):2990-9. PubMed ID: 7911070
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells.
Souès S; Laval F; Charcosset JY
Br J Cancer; 1995 Mar; 71(3):489-97. PubMed ID: 7880729
[TBL] [Abstract][Full Text] [Related]
59. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.
Kohno K; Sato S; Takano H; Matsuo K; Kuwano M
Biochem Biophys Res Commun; 1989 Dec; 165(3):1415-21. PubMed ID: 2575381
[TBL] [Abstract][Full Text] [Related]
60. mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.
Daly C; Coyle S; McBride S; O'Driscoll L; Daly N; Scanlon K; Clynes M
Cytotechnology; 1996; 19(3):199-205. PubMed ID: 8862007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]